Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells
Mitophagy is an evolutionarily conserved process that selectively targets impaired mitochondria for degradation. Defects in mitophagy are often associated with diverse pathologies, including cancer. Because the main known regulators of mitophagy are frequently inactivated in cancer cells, the mechan...
Main Authors: | Elodie Villa, Emma Proïcs, Camila Rubio-Patiño, Sandrine Obba, Barbara Zunino, Jozef P. Bossowski, Romain M. Rozier, Johanna Chiche, Laura Mondragón, Joel S. Riley, Sandrine Marchetti, Els Verhoeyen, Stephen W.G. Tait, Jean-Ehrland Ricci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124717312299 |
Similar Items
-
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin
by: Jina Yun, et al.
Published: (2014-06-01) -
Post-translational modification of Parkin and its research progress in cancer
by: Dan Ding, et al.
Published: (2019-11-01) -
Parkin contributes to synaptic vesicle autophagy in Bassoon-deficient mice
by: Sheila Hoffmann-Conaway, et al.
Published: (2020-05-01) -
The Transcription Factor Function of Parkin: Breaking the Dogma
by: Cristine Alves da Costa, et al.
Published: (2019-01-01) -
Will crystal Parkin help in understanding the future of Parkinson’s disease?
by: Diana Angelika Olszewska, et al.
Published: (2015-02-01)